{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:36Z","timestamp":1756902156625,"version":"3.44.0"},"reference-count":16,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:p>\n          <jats:bold>OBJECTIVES:<\/jats:bold> The purpose of this study is to determine how frequently children's hospitals in the United States are using pharmacist-physician collaborative drug therapy management (CDTM), and to characterize their use in this population.<\/jats:p>\n        <jats:p>\n          <jats:bold>METHODS:<\/jats:bold> A phone survey was created to collect data regarding the use of pharmacist-physician CDTM at children's hospitals. Children's hospitals were called between February 2014 and April 2014. Data were collected from either a clinical pharmacist or pharmacy director. Pharmacists were asked to answer questions regarding hospital demographics as well as to what extent and for which medications they use CDTM. Differences between types of hospitals were evaluated using Fisher exact test.<\/jats:p>\n        <jats:p>\n          <jats:bold>RESULTS:<\/jats:bold> A total of 171 children's hospitals were identified; 51.5% hospitals (n = 88) completed the survey. Of the 88 hospitals that completed the survey, 32 (31.7%) had some level of CDTM in place. Of the 28 children's hospitals with CDTM in place that completed the survey, all allowed pharmacists to modify doses and monitor therapy, and 75% provided pharmacists with the ability to initiate the first dose. The specific medications that were included in the CDTM protocols in children's hospitals included vancomycin (n = 23), aminoglycosides (n = 22), anticoagulation medications (n = 7), and total parenteral nutrition (n = 3). Training was required for pharmacists to participate in CDTM protocols at most hospitals (n = 26). Lack of support from medical staff was the most common perceived barrier. No differences were identified between types of children's hospitals.<\/jats:p>\n        <jats:p>\n          <jats:bold>CONCLUSION:<\/jats:bold> CDTM protocols are practiced in about one third of the children's hospitals. Pharmacists commonly initiate, monitor, and modify therapies as part of these protocols. The most frequently included medications were vancomycin and aminoglycosides.<\/jats:p>","DOI":"10.5863\/1551-6776-21.6.494","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T18:03:02Z","timestamp":1482343382000},"page":"494-501","source":"Crossref","is-referenced-by-count":0,"title":["Survey Evaluating the Practice of Children's Hospitals Having Pharmacist Collaborative Drug Therapy Management Protocols"],"prefix":"10.5863","volume":"21","author":[{"given":"Chelsea","family":"Welsh","sequence":"first","affiliation":[{"name":"University of Connecticut, Storrs, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukshana","family":"Miah","sequence":"additional","affiliation":[{"name":"University of Connecticut, Storrs, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Girotto","sequence":"additional","affiliation":[{"name":"University of Connecticut, Storrs, Connecticut"},{"name":"Connecticut Children's Medical Center, Hartford, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"key":"i1551-6776-21-6-494-b1","unstructured":"Koch\n              K.\n            \n          \n          Trends in collaborative drug therapy management. http:\/\/www.med-scape.com\/viewarticle\/409878. Accessed November 2, 2015.","article-title":"Trends in collaborative drug therapy management"},{"year":"2011","series-title":"Improving Patient and Health System Outcomes Through Advanced Pharmacy Practice: A Report to the U.S. Surgeon General","key":"i1551-6776-21-6-494-b2","unstructured":"Giberson\n              S\n            , YoderS, LeeMP.\n          Improving Patient and Health System Outcomes Through Advanced Pharmacy Practice: A Report to the U.S. Surgeon General. Washington, DC: Public Health Service, Office of the Chief Pharmacist; 2011."},{"issue":"4","key":"i1551-6776-21-6-494-b3","series-title":"Pharmacotherapy","first-page":"e39","article-title":"Collaborative drug therapy management and comprehensive medication management-2015","volume":"35","year":"2015","unstructured":"Mcbane\n              SE\n            , DoppAL, AbeA, \n          et al. Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy. 2015;35(4):e39\u2013e50."},{"issue":"9","key":"i1551-6776-21-6-494-b4","series-title":"Pharmacotherapy","first-page":"1210","article-title":"Collaborative drug therapy management by pharmacists--2003","volume":"23","year":"2003","unstructured":"Hammond\n              RW\n            , SchwartzAH, CampbellMJ, \n          et al. Collaborative drug therapy management by pharmacists--2003. Pharmacotherapy. 2003;23(9):1210\u20131225."},{"key":"i1551-6776-21-6-494-b5","unstructured":"Centers for Disease Control and Prevention. \n          Select features of state pharmacist collaborative practice laws. http:\/\/www.cdc.gov\/dhdsp\/pubs\/docs\/Pharmacist_State_Law.PDF. Accessed November 2, 2015.","article-title":"Select features of state pharmacist collaborative practice laws"},{"key":"i1551-6776-21-6-494-b6","series-title":"Am J Health Syst Pharm","first-page":"653","article-title":"ASHP national survey of pharmacy practice in acute care settings -- 1996","volume":"54","year":"1997","unstructured":"Reeder\n              C\n            , DicksonM, KozmaC, SantellJ.\n          ASHP national survey of pharmacy practice in acute care settings -- 1996. Am J Health Syst Pharm. 1997;54:653\u2013669."},{"issue":"24","key":"i1551-6776-21-6-494-b7","series-title":"Am J Health Syst Pharm","first-page":"2489","article-title":"Survey of pharmacist collaborative drug therapy management in hospitals","volume":"63","year":"2006","unstructured":"Thomas\n              J\n            , BharmalM, LinSW, PunekarY.\n          Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health Syst Pharm. 2006;63(24):2489\u20132499."},{"key":"i1551-6776-21-6-494-b8","series-title":"J Am Pharm Assoc","first-page":"e132","article-title":"Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements","volume":"53","year":"2013","unstructured":"American Pharmacists Association Foundation, American Pharmacists Association. \n          Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements. J Am Pharm Assoc. 2013;53:e132\u2013e141."},{"issue":"2","key":"i1551-6776-21-6-494-b9","series-title":"Am J Health Syst Pharm","first-page":"142","article-title":"ASHP national survey of pharmacy practice in acute care settings: prescribing and transcribing\u20141998: American Society of Health-System Pharmacists","volume":"56","year":"1999","unstructured":"Ringold\n              DJ\n            , SantellJP, SchneiderPJ, \n          et al. ASHP national survey of pharmacy practice in acute care settings: prescribing and transcribing\u20141998: American Society of Health-System Pharmacists. Am J Health Syst Pharm. 1999;56(2):142\u201357."},{"issue":"4","key":"i1551-6776-21-6-494-b10","series-title":"Int J Pharm Pract","first-page":"292","article-title":"Integrating pharmacists into primary care teams: barriers and facilitators","volume":"22","year":"2014","unstructured":"Jorgenson\n              D\n            , LaubscherT, LyonsB, \n          et al. Integrating pharmacists into primary care teams: barriers and facilitators. Int J Pharm Pract. 2014;22(4):292\u2013299."},{"key":"i1551-6776-21-6-494-b11","unstructured":"Measuring the impact of interprofessional education on collaborative practice and patient outcomes. http:\/\/iom.nationalacademies.org\/~\/media\/Files\/Report%20Files\/2015\/IPE_RAAG.pdf. Accessed November 10, 2015.","article-title":"Measuring the impact of interprofessional education on collaborative practice and patient outcomes"},{"issue":"2","key":"i1551-6776-21-6-494-b12","series-title":"Ann Fam Med","first-page":"188","article-title":"Interprofessional education","volume":"11","year":"2013","unstructured":"Iroku-malize\n              T\n            , MatsonC, FreemanJ, \n          et al. Interprofessional education. Ann Fam Med. 2013;11(2):188\u2013189."},{"key":"i1551-6776-21-6-494-b13","unstructured":"Accreditation Council for Pharmacy Education. \n          Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree. https:\/\/www.acpe-accredit.org\/pdf\/Standards2016FINAL.pdf. Accessed November 10, 2015.","article-title":"Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree"},{"key":"i1551-6776-21-6-494-b14","series-title":"Hum Relat","first-page":"1139","article-title":"Survey response rate levels and trends in organizational research","year":"2008","unstructured":"Baruch\n              Y\n            , HoltomBC.\n          Survey response rate levels and trends in organizational research. Hum Relat. 2008:1139\u20131160."},{"key":"i1551-6776-21-6-494-b15","series-title":"Arch Intern Med","first-page":"1939","article-title":"Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study","volume":"159","year":"1999","unstructured":"Gattis\n              WA\n            , HasselbladV, WhellanDJ, \n          et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999;159:1939\u20131945."},{"issue":"9","key":"i1551-6776-21-6-494-b16","series-title":"Ann Pharmacother","first-page":"1009","article-title":"Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center","volume":"49","year":"2015","unstructured":"Marquis\n              KA\n            , DegradoJR, LabonvilleS, \n          et al. Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center. Ann Pharmacother. 2015;49(9):1009\u20131014."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/6\/article-p494.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/21\/6\/494\/1784198\/1551-6776-21_6_494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/6\/article-p494.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/6\/article-p494.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:42:01Z","timestamp":1747356121000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/6\/article-p494.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-21.6.494","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2016]]}}}